Regulation of immune checkpoint blockade efficacy in breast cancer by FIP200: A canonical-autophagy-independent function

Immune checkpoint blockade (ICB) has emerged as a promising therapeutic strategy because of its potential to induce durable therapeutic responses in cancer patients. However, in the case of breast cancer, its application and efficacy has been limited. As such, combinatorial therapeutic strategies th...

Descripción completa

Detalles Bibliográficos
Autores principales: Yeo, Syn Kok, Guan, Jun-Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shared Science Publishers OG 2020
Materias:
Microreview
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7380453/
https://www.ncbi.nlm.nih.gov/pubmed/32743346
http://dx.doi.org/10.15698/cst2020.08.229

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7380453/
https://www.ncbi.nlm.nih.gov/pubmed/32743346
http://dx.doi.org/10.15698/cst2020.08.229

Ejemplares similares